Metformin treatment reduces temozolomide resistance of glioblastoma cells Article

Yang, Seung Ho, Li, Shenglan, Lu, Guangrong et al. (2016). Metformin treatment reduces temozolomide resistance of glioblastoma cells . 7(48), 78787-78803. 10.18632/oncotarget.12859

Open Access International Collaboration

cited authors

  • Yang, Seung Ho; Li, Shenglan; Lu, Guangrong; Xue, Haipeng; Kim, Dong H; Zhu, Jay-Jiguang; Liu, Ying

sustainable development goals

authors

publication date

  • November 29, 2016

keywords

  • CANCER STEM-CELLS
  • Cell Biology
  • FATTY-ACID SYNTHASE
  • GLIOMA-CELLS
  • IN-VITRO
  • INHIBITION
  • Life Sciences & Biomedicine
  • METASTASIS
  • Oncology
  • PROGRESSION
  • PROTEIN-INTERACTION NETWORKS
  • SOX2
  • Science & Technology
  • TUMOR-INITIATING CELLS
  • glioblastoma
  • global gene expression
  • metformin
  • temozolomide resistance

Digital Object Identifier (DOI)

publisher

  • IMPACT JOURNALS LLC

start page

  • 78787

end page

  • 78803

volume

  • 7

issue

  • 48